Truvada (emtricitabine / tenofovir disoproxil) vs Sunlenca (lenacapavir)
Truvada (emtricitabine / tenofovir disoproxil) vs Sunlenca (lenacapavir)
Truvada (emtricitabine/tenofovir disoproxil) is an antiretroviral medication commonly used for the treatment and prevention of HIV-1 infection in combination with other antiretrovirals, and it is administered orally as a daily pill. Sunlenca (lenacapavir) is a newer antiretroviral agent with a different mechanism of action, offering a long-acting treatment option for HIV-1 infection that can be administered every six months as an injection after an initial oral dosing phase. When deciding between Truvada and Sunlenca, one should consider factors such as dosing frequency, potential side effects, drug resistance profile, and the specific recommendations of a healthcare provider based on individual health needs and lifestyle.
Difference between Truvada and Sunlenca
Metric | Truvada (emtricitabine / tenofovir disoproxil) | Sunlenca (lenacapavir) |
---|---|---|
Generic name | Emtricitabine / Tenofovir disoproxil | Lenacapavir |
Indications | HIV-1 infection prevention and treatment | HIV-1 infection treatment in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection |
Mechanism of action | Reverse transcriptase inhibitors | HIV-1 capsid inhibitor |
Brand names | Truvada | Sunlenca |
Administrative route | Oral | Subcutaneous injection |
Side effects | Nausea, diarrhea, headache, fatigue, dizziness | Injection site reactions, nausea, insomnia, fatigue |
Contraindications | Patients with unknown or positive HIV-1 status, renal impairment, bone toxicity | Patients with previous hypersensitivity reaction to lenacapavir |
Drug class | Nucleoside Reverse Transcriptase Inhibitors (NRTIs) | HIV-1 capsid inhibitor |
Manufacturer | Gilead Sciences | Gilead Sciences |
Efficacy
Truvada (Emtricitabine / Tenofovir Disoproxil) for HIV/AIDS
Truvada, a combination of emtricitabine and tenofovir disoproxil, is a highly effective antiretroviral medication used in the treatment and prevention of HIV/AIDS. As part of a therapy regimen for individuals living with HIV, Truvada works by inhibiting the action of reverse transcriptase, an enzyme crucial for the replication of the virus. Clinical trials have demonstrated that when used in combination with other antiretroviral drugs, Truvada can significantly reduce the viral load in patients, often achieving undetectable levels, which helps to prevent the progression to AIDS and reduces the risk of HIV transmission.
In addition to its use in treatment, Truvada is also approved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at-risk adults and adolescents. Studies have shown that when taken consistently, Truvada for PrEP can reduce the risk of HIV infection by up to 92%. However, its efficacy is heavily dependent on adherence to the medication regimen.
Sunlenca (Lenacapavir) for HIV/AIDS
Sunlenca, which contains the active ingredient lenacapavir, represents a newer class of antiretroviral therapy with a novel mechanism of action. As a capsid inhibitor, lenacapavir interferes with multiple stages of the HIV-1 life cycle, including capsid assembly and disassembly, which are critical for viral replication. This unique mode of action provides a valuable option for individuals with multi-drug resistant HIV and those who have limited treatment options due to previous antiretroviral therapy failure.
The efficacy of Sunlenca has been evaluated in clinical trials involving heavily treatment-experienced individuals with multi-drug resistant HIV-1 infection. The results have indicated that lenacapavir, when used in combination with other antiretrovirals, can lead to significant reductions in viral load and an increase in CD4+ T-cell counts. This improvement is crucial for restoring the immune function in individuals with advanced HIV disease. The long-acting formulation of lenacapavir, which allows for dosing every six months, also aids in improving adherence and quality of life for patients.
Regulatory Agency Approvals
Truvada
Sunlenca
Access Truvada or Sunlenca today
If Truvada or Sunlenca are not approved or available in your country (e.g. due to supply issues), you can access them via Everyone.org.
How it works
Make an enquiry
Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.
Make an enquiry
Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.
Breeze through the paperwork
We'll guide you through the required documents for importing unapproved medicine, ensuring you have all the necessary information.
Get a personalized quote
We’ll prepare a quote for you, including medicine costs and any shipping, administrative, or import fees that may apply.
Receive your medicine
Accept the quote and we’ll handle the rest - sourcing and safely delivering your medicine.
Some text on this page has been automatically generated. Speak to your physician before you start a new treatment or medication.
Let's talk
If you have any questions, call us or send us a message through WhatsApp or email:
Contact us